Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Quantifying, Explaining and Predicting Survival After Diagnosis of HIV-related Kaposi Sarcoma in East Africa

Award Number: K43TW011987
ORGANIZATION: FOGARTY INTERNATIONAL CENTER
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 08/25/2021
PERIOD OF PERFORMANCE END DATE: 05/31/2027

Group Awards By:

View Award Description

Quantifying, Explaining and Predicting Survival After Diagnosis of HIV-related Kaposi Sarcoma in East Africa - Project Summary Among malignant complications of HIV infection in sub-Saharan Africa, one of the most common cancers in the pre-antiretroviral therapy (ART) era — Kaposi’s sarcoma (KS) — continues to be amongst the most common in the ART era. Despite a decline in mortality in the ART era, KS survival is still unacceptably poor, and many questions remain regarding mortality after KS diagnosis in the ART era. These questions span epidemiology and clinical management. With much yet to be learned, and as a direct response to the urgent need for effective strategies to improve survival of patients with HIV-related KS, the overall goal of this mentored career development proposal is to support Dr. Helen Byakwaga in acquiring the knowledge and skills to become an independent investigator in clinical and translational HIV-associated cancer research, with a focus on efforts to reduce KS mortality among HIV-infected individuals in Sub-Saharan Africa. Dr. Byakwaga has developed a research proposal linked to a career development plan, both of which are supported by a multi-faceted mentoring team that will guide her in completing the research and transitioning to an internationally competitive independent scientist. The specific aims are: Aim 1: Determine excess risk of mortality associated with KS among HIV-infected adults in East Africa; Aim 2: Identify potential biologic determinants of mortality among HIV-infected adults with a new diagnosis of KS; and Aim 3: Develop and validate a prediction model for mortality among individuals with HIV-related KS This project will determine the true magnitude of the impact of KS on mortality among HIV-infected individuals in the ART era, identify potential pathways that can be targeted to attenuate KS progression, and develop an algorithm to predict those at highest risk for death after KS diagnosis and for whom rapid interventions are most warranted. Overall, this proposal describes a comprehensive menu of research and career development activities consisting of mentoring and coursework that will help Dr. Byakwaga to achieve her research objectives and become an independent researcher.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $0 )
2026	2025	THE INFECTIOUS DISEASES INSTITUTE LIMITED	IDI-MCKINNELL KNOWLEDGE CENTRE	KAMPALA				UGA	International Research and Research Training	000	5	3/13/2026	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2025 ( Subtotal = $91,179 )
2025	2025	THE INFECTIOUS DISEASES INSTITUTE LIMITED	IDI-MCKINNELL KNOWLEDGE CENTRE	KAMPALA				UGA	International Research and Research Training	000	5	6/30/2025	NON-COMPETING CONTINUATION	$91,179
														Subtotal = $91,179

Issue Date FY: 2024 ( Subtotal = $91,559 )
2024	2024	THE INFECTIOUS DISEASES INSTITUTE LIMITED	IDI-MCKINNELL KNOWLEDGE CENTRE	KAMPALA				UGA	International Research and Research Training	000	4	5/6/2024	NON-COMPETING CONTINUATION	$91,559
														Subtotal = $91,559

Issue Date FY: 2023 ( Subtotal = $101,279 )
2023	2023	INFECTIOUS DISEASES INSTITUTE LIMITED	MULAGO HOSPITAL COMPLEX	KAMPALA				UGA	International Research and Research Training	000	3	5/1/2023	NON-COMPETING CONTINUATION	$101,279
														Subtotal = $101,279

Issue Date FY: 2022 ( Subtotal = $101,726 )
2022	2022	INFECTIOUS DISEASES INSTITUTE LIMITED	MULAGO HOSPITAL COMPLEX	KAMPALA				UGA	International Research and Research Training	000	2	5/17/2022	NON-COMPETING CONTINUATION	$101,726
2022	2021	INFECTIOUS DISEASES INSTITUTE LIMITED	MULAGO HOSPITAL COMPLEX	KAMPALA				UGA	International Research and Research Training	001	1	5/20/2022	NEW	$0
														Subtotal = $101,726

Issue Date FY: 2021 ( Subtotal = $102,914 )
2021	2021	INFECTIOUS DISEASES INSTITUTE LIMITED	MULAGO HOSPITAL COMPLEX	KAMPALA				UGA	International Research and Research Training	000	1	8/27/2021	NEW	$102,914
														Subtotal = $102,914

Grand Total All Awards = $488,657

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Quantifying, Explaining and Predicting Survival After Diagnosis of HIV-related Kaposi Sarcoma in East Africa

Award Number: K43TW011987

ORGANIZATION: FOGARTY INTERNATIONAL CENTER

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 08/25/2021

PERIOD OF PERFORMANCE END DATE: 05/31/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer